Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AB4T: Antitussive, anticholinergic and honey vs usual practice in acute bronchitis
2018-002563-25Phase 4Terminated
- Sponsor
- IDIAPJGol
- Start
- Aug 2018
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dextromethorphan, ipratropium bromide and Revamil in acute bronchitis and cough (4 arms), sponsored by IDIAPJGol. Primary endpoint: Duration of moderate-severe cough. Started Aug 2018; status: terminated.
02
Drugs
dextromethorphanipratropium bromideRevamil
03
Conditions
acute bronchitiscough
Beyond the preview
Go deeper on 2018-002563-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002563-25.